List of Therapeutic Companies in Nebraska - 2

AngioDesign is developing the first truly-novel, next-generation combination inhibitors (C-domain ACE, C-domain ACE/NEP, N-domain ACE) with the potential to treat a number of the most important conditions impacting human health today, including heart failure, hypertension and fibrosis. Cardiovascular disease is the single most common cause of death in the world. AngioDesign’s drug discovery platform is focused on the rational design and development of improved, next-generation drugs for proven disease targets and its initial focus is on the development of inhibitors of angiotensin-converting enzyme. AngioDesign uses a lean management approach in its quest to optimize this effort.

Leading with Science™, Synbiotic Health develops, clinically researches and markets Ecologically-Advanced™ probiotics for improved health. Using our novel discovery platforms IVS™ and IVE™ Synbiotic Health is pioneering a new category of Synergistic Synbiotics™— proprietary select combinations of Ecologically Advanced™ probiotics and prebiotics that change the microbiome to provide documented health benefits. Our science relies on understanding the ecological framework in the gut and how beneficial bacteria become established and compete with the resident microbes. At Synbiotic Health we consider the entire ecosystem, specific traits, and functions necessary for probiotics to support human health and outperform existing offerings in the market. Better Science for Better Health™